Pre-made Adalimumab biosimilar ( Whole mAb, anti-TNFA therapeutic antibody) - benchmark reference antibody
Cat No.: GMP-Bios-ab-009
Anti-TNFA therapeutic antibody (Pre-made Adalimumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Adalimumab, sold under the brand name Humira, among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. Use is generally only recommended in people who have not responded to other treatments. It is administered by injection under the skin.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Anti-TNFA therapeutic antibody (Pre-made Adalimumab biosimilar,Whole mAb)|
|Highest_Clin_Trial (Jan '20)||Approved|
|100% SI Structure||6cr1:HL/4nyl:AB:CD:EF:HL|
|99% SI Structure||3wd5:HL|
|95-98% SI Structure||None|
|Companies||Abbvie;MedImmune;180 Life Sciences|
|Conditions Approved||Ankylosing spondylitis;Behcet's syndrome;Crohn's disease;Hidradenitis suppurativa;Juvenile rheumatoid arthritis;Plaque psoriasis;Psoriatic arthritis;Pustular psoriasis;Rheumatoid arthritis;Spondylarthritis;Ulcerative colitis;Uveitis;Pyoderma|
|Conditions Active||Dupuytren's contracture;Cognition disorders;Frozen shoulder;Non-alcoholic steatohepatitis|
|Conditions Discontinued||Interstitial cystitis|
|Development Tech||CAT Phage Display|